Central Taiwan

【Tungs Hospital】Halcyon™: Treat & Monitor | Cancer Radiotherapy
【Tungs Hospital】Halcyon™: Treat & Monitor | Cancer Radiotherapy

Mr. Ramon from the Philippines was diagnosed with stage IV lung cancer years ago, with metastasis to the bones that caused him to endure severe spinal pain over a long period of time. On a friend’s recommendation, he decided to come to Taiwan for radiotherapy. Upon arrival, Mr. Ramon relied on a wheelchair, assisted by airline staff at Taoyuan International Airport, and was then transferred to our hospital by shuttle service for admission and treatment. After receiving Halcyon™ radiotherapy, his condition improved significantly; by the time of discharge, he was able to walk independently without the need for a wheelchair. Even after returning home, both his pain and cancer progression have remained under control. Dr. Chih-Yuan Yeh, Director of the Department of Radiation Oncology at Tungs’ Hospital, emphasized that radiotherapy plays a crucial role in cancer treatment, commonly used to shrink tumors, kill cancer cells, and relieve symptoms. A single course of radiotherapy may take several weeks and involve dozens of sessions. During this period, the tumor itself may change in size or position due to treatment. Without timely monitoring and adjustment of the treatment plan, such changes could lead to dosage inaccuracies, affecting both the effectiveness of the therapy and the safety of surrounding healthy tissues. Hypersight Navigation Speeds Up Positioning and Enables Precise Adaptive Radiotherapy In the past, radiotherapy positioning relied on conventional image guidance, which was often limited by insufficient image resolution and lengthy processing times, restricting the ability to make real-time adjustments. The newly introduced Halcyon™ system, equipped with Hypersight technology, can capture cone-beam CT images in just six seconds and directly calculate dosage on the images. With image quality comparable to diagnostic CT scans and a field of view covering the entire tumor region and surrounding critical organs, it helps physicians assess patient positioning, tumor location, and volume changes—greatly enhancing treatment accuracy. This technology also advances the practice ofAdaptive Radiotherapy. Dr. Chih-Yuan Yeh explained that this approach allows physicians to fine-tune treatment parameters based on the patient’s daily condition, transforming radiotherapy from a single fixed plan into a dynamic, real-time adjusted process—achieving truly precise and personalized care. Dr. Chia-Hua Yen, attending physician in the Department of Radiation Oncology, added that for cancers such as prostate cancer, where tumors are located near the bladder and rectum, their position may shift due to urination or weight changes. Halcyon’s combination of rapid navigation and adjustment capabilities can correct these shifts in real time, preventing dosage errors, improving treatment effectiveness, and reducing the risk of side effects. Dr. Chia-Hua Yen, attending physician in the Department of Radiation Oncology, added that for cancers such as prostate cancer, where tumors are located near the bladder and rectum, their position may shift due to urination or weight changes. Halcyon’s combination of rapid navigation and adjustment capabilities can correct these shifts in real time, preventing dosage errors, improving treatment effectiveness, and reducing the risk of side effects. Clinical Case Highlights: Tumor Shrinkage Increases Chance of Cure Patients at Tungs’ Hospital have already benefited from this advanced technology. One 57-year-old patient was diagnosed with stage I oral cancer in 2024. Although surgery initially went well, later that year a 0.5 cm tumor reappeared on the lip, followed by a large tumor of about 350 cubic centimeters extending from the cheek to the shoulder and neck. Because of the tumor’s size and the high surgical risk, the medical team decided to begin treatment with Halcyon™ radiotherapy. Over the course of one and a half months, the patient underwent 35 radiotherapy sessions, with Hypersight imaging scans performed daily to monitor tumor size and positioning. By the end of treatment, the tumor volume had shrunk from 350 cc to around 200 cc. This allowed the patient to successfully continue with chemotherapy and surgery, significantly improving the likelihood of complete tumor removal. Dr. Chih-Yuan Yeh noted that despite the intensive regimen, the patient tolerated treatment well, showing how new technology can boost both treatment tolerance and patient confidence. Precision and Real-Time Benefits: Helping Patients with Metastatic Disease Dr. Yeh further explained that Halcyon™ is suitable for a wide range of cancers, offering particular advantages for patients with widespread or complex tumors. For example, patients with multiple lung metastases were once considered unsuitable for radiotherapy. Today, by combining Halcyon™ with stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), multiple lesions can be treated safely and precisely with high doses. He also cited international clinical research showing that patients with nasopharyngeal and head and neck cancers who received adaptive radiotherapy achieved a 10% higher 5-year survival rate. To date, more than 200 patients have received high-quality treatment using the Halcyon™ system at Tungs’ Hospital. President Min-Che Tung emphasized that precision and timeliness are at the core of cancer treatment. The introduction of Halcyon™ demonstrates the hospital’s commitment to patient health and reflects its mission to use innovative technology and quality care to guide more cancer patients toward recovery. -- Official Website:https://tconf.sltung.com.tw/imc/ FB:https://www.facebook.com/ttmhhimsc/ Email: thimsc.tung@gmail.com

#Cancer Treatment
[Taiwan–Malaysia Medical Innovation Forum] CMUH and UNIMAS Co-Host Major Medical Symposium to Advance Medical Technology and Precision Patient Care
[Taiwan–Malaysia Medical Innovation Forum] CMUH and UNIMAS Co-Host Major Medical Symposium to Advance Medical Technology and Precision Patient Care

Following the signing of a Memorandum of Understanding (MOU) in 2024, Taiwan’s China Medical University Hospital (CMUH) and Malaysia’s Universiti Malaysia Sarawak (UNIMAS) have established a long-term collaborative partnership aimed at driving innovation in healthcare. On 12th July, in Kuching, Sarawak, the two institutions co-hosted their first major academic event – a joint symposium titled “Advances in Medical Technology and Patient Care Symposium.” This symposium spotlighted frontier advancements in medical technology and clinical care, including obesity management, cancer proton therapy, medical artificial intelligence, Parkinson’s disease interventions, and atrial fibrillation treatment. In his opening remarks, Dr. Chih-Kun Huang, Superintendent of International Center at CMUH, remarked, “This symposium not only showcases Taiwan’s achievements in precision medicine and innovation but also marks a new chapter of collaboration with Malaysia. We look forward to deepening our shared mission of improving health outcomes across borders.” o:p>/o:p> v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">v:stroke joinstyle="miter">v:formulas>v:f eqn="if lineDrawn pixelLineWidth 0">v:f eqn="sum @0 1 0">v:f eqn="sum 0 0 @1">v:f eqn="prod @2 1 2">v:f eqn="prod @3 21600 pixelWidth">v:f eqn="prod @3 21600 pixelHeight">v:f eqn="sum @0 0 1">v:f eqn="prod @6 1 2">v:f eqn="prod @7 21600 pixelWidth">v:f eqn="sum @8 21600 0">v:f eqn="prod @7 21600 pixelHeight">v:f eqn="sum @10 21600 0">/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:f>/v:formulas>v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect">o:lock v:ext="edit" aspectratio="t">/o:lock>/v:path>/v:stroke>/v:shapetype>v:shape id="圖片_x0020_1" o:spid="_x0000_s1026" type="#_x0000_t75" style="position:absolute;left:0;text-align:left;margin-left:0;margin-top:22.65pt; width:415.6pt;height:202.6pt;z-index:-251658240;visibility:visible; mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0; mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt; mso-wrap-distance-bottom:0;mso-position-horizontal:left; mso-position-horizontal-relative:margin;mso-position-vertical:absolute; mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0; mso-width-relative:page;mso-height-relative:page">v:imagedata src="file:///C:/Users/f09/AppData/Local/Temp/msohtmlclip1/01/clip_image001.jpg" o:title="">w:wrap type="tight" anchorx="margin">/w:wrap>/v:imagedata>/v:shape> China Medical University Hospital (CMUH) in Taiwan and Universiti Malaysia Sarawak (Unimas) co-hosted the '2025 Advances in Medical Technology and Patient Care Symposium' in Kuching on July 12, attracting over 200 participants and receiving an enthusiastic response.o:p>/o:p> Multidisciplinary Strategies in Obesity Treatment: A New Era of Innovationo:p>/o:p> Dr. Chih-Kun Huang, Superintendent of International Center, CMUH, shared insights in his keynote titled “The Trend and Future of Obesity Treatment.” He addressed the global obesity epidemic and the limitations of conventional methods such as lifestyle modification and pharmacotherapy. Dr. Huang highlighted the emergence of novel anti-obesity agents targeting appetite and energy regulation, along with hormonal modulation following bariatric surgery. He also emphasized the role of genetic and microbiome-based approaches in advancing personalized interventions, and the growing potential of endoscopic bariatric therapies as less invasive alternatives. Dr. Huang stressed that the future of obesity treatment lies in a multidisciplinary framework combining medical, behavioral, and technological strategies—especially relevant in countries like Malaysia where obesity prevalence is rising.o:p>/o:p> Proton Therapy in Cancer Treatment: Precision with Fewer Side Effectso:p>/o:p> Dr. Chun-Ru Chien, Director of Radiation Oncology Department at CMUH, delivered a presentation on “Proton Therapy in Cancer Treatment.” He compared conventional photon-based radiotherapy with proton therapy, an advanced modality offering superior dose conformity to tumors while sparing surrounding healthy tissue. Dr. Chien emphasized the clinical benefits for patients in both Taiwan and Malaysia and introduced CMUH’s new proton therapy center, established in 2024—Taiwan’s fifth and most advanced to date—signaling a commitment to global cancer care excellence.o:p>/o:p> Medical AI: A Foundational Driver of Precision Medicineo:p>/o:p> Dr. Wan-Yuo Guo, M.D., Ph.D., President of World Federation of Neuroradiological Societies (WFNRS), shared his expert perspective on “Medical AI as a Foundational Driver of Precision Medicine.” Dr. Guo illustrated how AI is revolutionizing healthcare by enabling integration and analysis of complex, multimodal datasets—such as imaging, genomics, pathology, and clinical records. He focused particularly on imaging AI’s ability to enhance diagnostic accuracy, detect disease earlier, and assist with personalized risk stratification. He also discussed the role of federated learning and AI-driven clinical decision support systems, highlighting AI’s transition from supportive technology to a central enabler of predictive, preventive, and participatory medicine.o:p>/o:p> Dual-Target MRgFUS: A Breakthrough in Parkinson’s Disease Careo:p>/o:p> Dr. Jui-Cheng Chen, Director of Neurology Department at CMUH, introduced a groundbreaking advancement in movement disorder treatment with his talk on “Revolutionizing Parkinson’s Care: Dual-Target MRgFUS for Comprehensive Symptom Relief.” He presented the world’s first dual-target MR-guided Focused Ultrasound (MRgFUS) procedure, which simultaneously ablates the ventral intermediate nucleus (VIM) and the pallidothalamic tract (PTT). This innovation offers comprehensive relief for Parkinson’s symptoms, addressing both tremor and rigidity in a non-invasive, incision-free manner. For patients ineligible for deep brain stimulation, this minimally invasive therapy with immediate results and high safety is redefining standard care in Parkinson’s management.o:p>/o:p> Atrial Fibrillation: Concomitant Ablation and LAA Closure for Better Outcomeso:p>/o:p> Dr. Yen-Nien Lin, MD, Director of Cardiac Arrhythmia Center, CMUH, presented on “Best Atrial Fibrillation Management: Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Closure—The CMUH Experience.” He outlined an integrated treatment approach for patients with symptomatic AF and elevated stroke risk, combining catheter ablation with left atrial appendage closure (LAAC) in a single procedure. This strategy addresses both arrhythmogenic foci and thromboembolic sources, reducing the need for lifelong anticoagulation. Drawing on findings from major clinical trials like aMAZE and AMULET IDE, Dr. Lin discussed procedural techniques, device deployment, and post-operative management—emphasizing the value of a tailored, multidisciplinary protocol to enhance long-term patient outcomes.o:p>/o:p> From the UNIMAS side, Prof. Dr. Edmund Sim, from the Faculty of Resource Science and Technology, introduced CARISA (Cancer Risk Assessment Toolkit), a multilingual digital platform designed to empower Malaysians in early self-assessment of cancer risks. o:p>/o:p> Early Cancer Detection through CARISA Toolkito:p>/o:p> Highlighting the burden of cancers such as breast, nasopharyngeal, cervical, lung, and colorectal in Malaysia, Prof. Edmund emphasized the critical need for culturally adapted, evidence-based tools that enable personalized, pre-symptomatic risk screening. CARISA, a subscription-based toolkit, integrates five disease-specific modules, i.e., BreCRA, NasoCRA, CerviCRA, LunCRA, and ColoCRA, each built on Malaysian national cancer registry data, systematic reviews, and clinical expert consensus. As noted by Prof Edmund, what makes CARISA unique is not just its scientific rigor, but its inclusivity within the Sarawakian context. The tool supports English, Malay, Mandarin, and Iban languages, mirroring the rich linguistic diversity of Malaysia, especially in Sarawak. o:p>/o:p> Otology Implants: Transforming Hearing Careo:p>/o:p> Meanwhile, Prof. Dr. Ing Ping Tang, a senior consultant in Otorhinolaryngology Head and Neck Surgery (ORL-HNS) from the Faculty of Medicine and Health Sciences, presented a review on new advances in otology implants that have expanded beyond traditional cochlear devices. His session provided a deep dive into various implantable technologies, including Bone Conduction Implant, Cochlear Implant, Middle Ear Implant, Passive Middle Ear Implant and also Auditory Brainstem Implants. Of particular interest were discussions around extended candidacy for patients with atypical anatomies or minimal benefit from conventional hearing aids. o:p>/o:p> This symposium marks the first large-scale academic collaboration between CMUH and UNIMAS since the signing of their MOU, and sets a new benchmark for medical innovation, education, and cross-border collaboration. By facilitating knowledge exchange and showcasing precision medicine advancements, this event exemplifies a joint commitment to improving healthcare outcomes across Asia and beyond.
【Tungs' Hospital】 Former Stage III Prostate Cancer Patient Shares Da Vinci Surgery Experience
【Tungs' Hospital】 Former Stage III Prostate Cancer Patient Shares Da Vinci Surgery Experience

Learn More About【Tungs' Hospital】 figure class="wp-block-uagb-image__figure" style="box-sizing: inherit; margin: 0px; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; position: relative; display: flex; flex-direction: column; max-width: 100%; height: auto;">/figure> Tung’s Taichung MetroHarbor Hospital Continues to Lead in Medical Innovation – Former Patient Shares Inspiring Recovery Journey With 54 years of dedication to patient-centered care, Tungs’ Taichung MetroHarbor Hospital has consistently pursued medical innovation and excellence. In 2012, the hospital became one of Taiwan’s early adopters of the Da Vinci Surgical System. Thirteen years later, it has performed over 5,000 robot-assisted surgeries and now operates two state-of-the-art 4th-generation Da Vinci systems, making it one of the few hospitals in Taiwan with this advanced dual setup. Multi-specialty Collaboration Enhances Precision and Efficiency The Da Vinci system at Tungs’ Hospital is utilized across eight surgical specialties: Thoracic Surgery, Urology, ENT, Obstetrics & Gynecology, General Surgery, Colorectal Surgery, Cardiovascular Surgery, and Pediatric Surgery. By integrating multi-specialty collaboration, the hospital significantly improves surgical precision, reduces recovery time, and enhances overall patient care quality. Some patients even receive coordinated surgeries across departments during a single hospitalization, optimizing both time and medical outcomes. Dr. Yen-Chuan Ou, Director of the Innovation and Research Center, emphasized the continuous refinement of robotic-assisted surgery at Tungs’. From enhanced instrument selection to evidence-based surgical planning, the hospital provides comprehensive care from preoperative evaluation to postoperative recovery. The robot’s high-definition, magnified 3D imaging allows for clearer visualization of blood vessels and nerves, improving both surgical safety and patient recovery. A Life Restored: FormerStage III Prostate CancerPatient Shares Da Vinci Surgery Experience To mark the achievement of over 5,000 Da Vinci surgeries, the hospital hosted a press conference titled “A New Era of Innovation: Breaking 5,000 Da Vinci Cases”, inviting distinguished guests and featuring a moving story from a former patient. Mr. Wu, now 77 years old, underwent Da Vinci-assisted radical prostatectomy at Tungs’ 11 years ago after being diagnosed with stage III prostate cancer. Initially devastated by the diagnosis, he recalled how the medical team, led by Dr. Yen-Chuan Ou, thoroughly explained the treatment plan and reassured him about the robotic surgery. To his surprise, the surgery was nearly painless, and he was able to walk the very next day and was discharged shortly thereafter. With regular follow-up and care, Mr. Wu’s health remains excellent. “I truly got my life back,” he said gratefully. “Thanks to the medical team at Tungs’, I’m living a normal, healthy life again.” figure class="wp-block-uagb-image__figure" style="box-sizing: inherit; margin: 0px; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; position: relative; display: flex; flex-direction: column; max-width: 100%; height: auto;">/figure> A Global Center for Robotic Surgery and Medical Collaboration Over the years, Tungs’ Hospital has become a hub for international medical exchange and surgical observation. Patients now come from Southeast Asia, Europe, and North America, and the hospital welcomes surgeons from around the world to train and observe, particularly in Urology, ENT, and Gynecology, where it is recognized as a world-class center for robotic-assisted surgery. The hospital also organizes the Tungs’ International Congress Series (TICS) annually, providing a high-level platform for global academic exchange in robotic surgery. The event attracts leading medical professionals to share clinical insights, foster innovation, and raise the international standard of care. Superintendent Dr. Tung Min-Che noted that the hospital remains committed to advancing with the latest medical technologies. In 2025, Tungs’ will introduce the new single-port Da Vinci system, expanding its capabilities in minimally invasive and cosmetic procedures. “Our mission is to lead the way in robotic surgery in Asia,” said Dr. Tung. “By investing in advanced equipment and interdisciplinary expertise, we aim to provide patients with safer, more comfortable, and internationally competitive surgical care. -- Official Website:https://tconf.sltung.com.tw/imc/ FB:https://www.facebook.com/ttmhhimsc/ Email: thimsc.tung@gmail.com

#Joint Replacement#Cardiovascular Surgery#Cancer Treatment#Robotic Surgery#Medical Tourism
【Tungs' Hospital】U.S. Teacher Regained Hope After Devastating Car Accident
【Tungs' Hospital】U.S. Teacher Regained Hope After Devastating Car Accident

TAICHUNG, TAIWAN– A 59-year-old American teacher, William, has returned home to the U.S. after surviving a catastrophic motorcycle accident that left both of his legs severely crushed. Thanks to the expertise of doctors at Tungs’ Hospital in Taiwan, he not only survived but also regained the ability to walk. William had been teaching English in Taiwan for about six months when tragedy struck. A truck ran over both of his legs, resulting inmark class="has-inline-color has-ast-global-color-0-color" style="box-sizing: inherit; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: "Source Sans 3", sans-serif; font-size: 17px;">massive blood loss and severe open fractures below the knees/mark>. Rushed to Tungs’ Hospital, he faced life-threatening injuries that required immediate surgical intervention. A team of specialists, led byDr. Cheng Yu-Chieh(鄭宇傑) from the Department of Orthopedics andDr. Tsai Ying-Han(蔡穎瀚) from the Department of Plastic Surgery, performed a series of critical operations. His left leg was too damaged to be saved, necessitating anabove-the-knee amputation. However, doctors worked tirelessly to preserve his right leg through complex microsurgical procedures, includingmark class="has-inline-color has-ast-global-color-1-color" style="box-sizing: inherit; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">internal fixation and a microsurgical flap transplant/mark>. After enduring nine surgeries and more than ten hours of microsurgery, his right lower limb was saved. William’s road to recovery was arduous. He spent over a month in the intensive care unit and another month in a general ward. Upon discharge, he was transferred to theRemaintain Prosthetics Center, where he received a prosthetic limb and underwent intensive rehabilitation. Three months of training allowed him to stand with a walker and take short steps. By the sixth month, he was able to walk independently for longer distances. In January of this year, he was finally strong enough to return to the U.S. Reflecting on his experience, William expressed profound gratitude. “After the accident, I felt completely hopeless. But thanks to the incredible medical team at Tungs’ Hospital, I got a second chance at life,” he said. He creditedDr.TsaiYing-Han(蔡穎瀚) for his unwavering commitment to exploring every possible treatment and the dedicated healthcare staff and rehabilitation specialists who supported his recovery. Dr. Tsai(蔡穎瀚) emphasized that William’s case was extremely challenging. “Both of his legs suffered devastating injuries. We had to act quickly to save his life and make every effort to preserve mobility in his right leg,” he explained. “Had both legs been amputated, standing and walking would have been significantly more difficult. His trust in Taiwan’s medical system and his resilience played a major role in his recovery.” William’s journey serves as a testament to the power of advanced medical care, teamwork, and perseverance. Though he lost a leg, he regained the ability to walk—and with it, the chance to rebuild his future. -- More About [Tungs' Hospital-Taiwan Medical Travel] Visit [Formosa Tungs+ International Medical Service-Official Website]
【Tungs’ Hospital】 Earns 4-Star in Global Hospital Rankings
【Tungs’ Hospital】 Earns 4-Star in Global Hospital Rankings

Tungs’ Hospital Earns 4-Star Recognition in the “World’s Best Hospitals” Rankings Over its 53-year history, Tungs’ Hospital has continuously improved the quality of its medical services, earning widespread international recognition for its outstanding achievements. At the end of last year, the hospital successfully passed the Joint Commission International (JCI) accreditation for the sixth time. Recently, it garnered a prestigious 4-star rating in the “World’s Best Hospitals” rankings, organized by the renowned media outletNewsweekin collaboration with global data firm Statista. This accolade positions Tungs’ Hospital as a shining representative in the worldwide healthcare system. The “World’s Best Hospitals” rankings evaluate five key aspects: medical care services, timeliness of care, patient safety, IT and medical technology, and workplace advantages and benefits. Experts from around the globe verify and assess data in a comprehensive review, assigning hospitals star ratings ranging from 1 to 5. Tungs’ Hospital received high praise across all five categories, culminating in its 4-star rating. Tungs’ Hospital delivers exceptional timeliness in care, ensuring a physician evaluates patients within 10 minutes of arriving at the emergency department. The hospital boasts a highly skilled professional team, including psychologists, physical therapists, occupational therapists, respiratory therapists, speech therapists, dietitians, and a full medical and nursing staff complement. It also provides specialized pharmacy, radiology, and case management teams, ensuring round-the-clock critical care. The emergency department team is committed to evaluating patients within 10 minutes of their arrival, employing process optimization and wait-time analysis to significantly reduce patient waiting times and enhance the timeliness of care. Furthermore, the hospital actively collects feedback from patients and their families for continuous improvement. It has implemented rigorous management protocols for firefighting and infection control, conducting regular drills to enhance patient safety. Tungs’ Hospital continuously adopts cutting-edge technologies and equipment to provide innovative services, aiming to deliver the highest quality of care centered on patient needs. In addition to introducing AI-powered systems and globally advanced medical technologies, the hospital has upgraded its information systems with strict cybersecurity measures, earning ISO 27001 and 27999 certifications. The hospital also utilizes the HIMSS Electronic Medical Record Adoption Model (EMRAM) for analytics. In terms of workplace advantages and benefits, Tungs’ Hospital fosters a supportive work environment with various employee perks, such as travel subsidies, bonuses, accommodations, fitness facilities, and learning and development programs, creating a comprehensive and fulfilling healthcare system for staff. The hospital also fosters a fulfilling workplace, creating a comprehensive and supportive environment for staff. Dr. Tung Min-Che, the hospital’s president, stated that Tungs’ Hospital will uphold its commitment to innovation and excellence, continuously enhancing medical services to safeguard the health and well-being of every patient, with the ultimate goal of achieving a 5-star rating. 2024Global Hospital Rankings Video Go to【Tungs' MetroHarbor Hospital】
Heart Surgery for Mitral Valve Regurgitation
Heart Surgery for Mitral Valve Regurgitation

【Tungs' MetroHarbor Hospital】 Tungs’ Hospital introduced the Da Vinci robotic surgical system as early as 2012 and further upgraded it in 2021 with two fourth-generation Da Vinci robotic systems. That same year, Dr. Cheng Po-Chih, a renowned cardiac surgeon with over 30 years of experience and approximately 520 Da Vinci heart surgeries, was appointed Vice President of the hospital. Under his leadership, the cardiac surgery team has consistently innovated, performing groundbreaking procedures and helping over 100 patients regain their health through minimally invasive heart surgeries, improving the lives of countless families. In June, the hospital held an event to celebrate its milestone of surpassing 100 successful Da Vinci minimally invasive heart surgeries. Among the attendees was Ms. Sun, a 29-year-old patient who shared her recovery journey and expressed gratitude to Dr. Cheng, Dr. Kuo Chia-Cheng, and the medical team. Ms. Sun had experienced unexplained hemoptysis in June of the previous year, which led her to an emergency room visit at a nearby hospital. She was diagnosed with pulmonary edema caused by severe mitral valve regurgitation, necessitating urgent mitral valve replacement surgery. Mitral valve regurgitation, a heart valve disorder, occurs when the mitral valve fails to close completely, allowing blood to flow backward from the left ventricle to the left atrium. If untreated, it can lead to complications such as pulmonary edema, arrhythmia, or heart failure. Understandably, Ms. Sun was anxious about undergoing heart surgery and worried about the aesthetic impact of surgical scars due to her young age. Following recommendations from friends and family, she sought treatment from Dr. Cheng at Tungs’ Hospital. After a thorough evaluation, Dr. Cheng recommended Da Vinci minimally invasive mitral valve replacement surgery to meet her medical needs and personal preferences. The surgery, performed on August 23, was successful. Ms. Sun recovered well, spending just one day in the intensive care unit before being transferred to a regular ward. She was discharged within seven days to continue her recovery at home. Ms. Sun expressed her heartfelt gratitude to Dr. Cheng, Dr. Kuo, and the medical team, sharing how her health improved significantly post-surgery. Before the procedure, her heart rate would spike to 170 bpm during exercise, but it now stabilizes at 130 bpm with no discomfort or fatigue. She also appreciated the minimal scarring, which preserved her aesthetic concerns, crediting the hospital’s advanced medical technology and expertise. Vice Superintendent Cheng Bo-Chih stated that traditional sternotomy-based heart surgeries, which have been performed for over 70 years, remain highly reliable and are still considered the most direct and effective surgical approach. However, the long scar on the chest from the procedure has been a psychological burden for many heart disease patients. Issues such as post-operative pain and slow recovery have discouraged older patients, those with limited mobility, or individuals with compromised organ function from pursuing treatment. Consequently, the pursuit of minimally invasive and fast-recovery heart surgeries has become not only a patient expectation but also the ultimate goal for surgeons. This is why the da Vinci robotic-assisted minimally invasive heart surgery has emerged as the preferred choice for both patients and doctors. The cardiac surgery team at Tungs’ Hospital has been continuously advancing in performing da Vinci robotic-assisted heart surgeries. First Advancement: They have combined the da Vinci system with a hybrid X-ray fluoroscopy system to simultaneously treat damaged heart valves and coronary artery blockages. This eliminates the psychological stress patients face from requiring a second surgery and accelerates post-operative recovery. Second Breakthrough: By integrating the da Vinci system with a myoma morcellator, the team successfully removed an 8 cm heart tumor through a 1 cm incision, ensuring precision and minimal invasiveness. Third Innovation: They combined the da Vinci robotic arms with sterile ultrasound technology to enable simultaneous diagnosis and treatment. This approach effectively addresses complex conditions such as hypertrophic cardiomyopathy with mitral valve regurgitation, without the need to replace the mitral valve. This spares patients the lifelong requirement of taking anticoagulant medication. Dr. Cheng emphasized that while both traditional sternotomy-based surgeries and da Vinci minimally invasive surgeries can address cardiac conditions, structures like the mitral valve, tricuspid valve, left atrial tumors, atrial fibrillation, and hypertrophic cardiomyopathy involve deep cardiac anatomy. Traditional surgeries require opening the sternum and using elongated instruments to access these areas. In contrast, the da Vinci robotic arms approach the heart from the right side and target the back of the heart directly at the affected area. This method eliminates the need for sternotomy and the tedious steps of hemostasis. By minimizing tissue damage and improving post-operative pain, some patients can even walk and perform rehabilitation exercises in the intensive care unit shortly after being taken off the ventilator. Currently, 54 hospitals in Taiwan have installed 72 Da Vinci robotic systems, making the country a global leader in adopting this advanced technology. Dr. Cheng urged patients not to fear heart disease or surgery, as consulting a skilled cardiac surgeon and following a tailored treatment plan can effectively resolve their condition. Dr. Tung Min-Che, the hospital’s president, affirmed that Tungs’ Hospital remains committed to patient-centered care, continuously introducing state-of-the-art technology to meet international standards. The Da Vinci robotic system is employed across various specialties, including cardiothoracic, urology, general surgery, ENT, gynecology, colorectal, pediatric, and thoracic surgery. With nearly 5,000 Da Vinci surgeries performed, Tungs’ Hospital plans to expand its capabilities further, ensuring patients receive the highest quality of care. If you have further questions: Read the article 【What You Need to Know About Mitral Valve Regurgitation】 Contact 【Tungs’ Hospital International Medical Center】 Visit 【IMedS Facebook Page】 for more information.

#Cardiovascular Surgery#Robotic Surgery#Medical Tourism
【Tungs' Hospital】Gastroscopy and Colonoscopy Reveal Hidden Tumors: Tungs' Hospital Helps Patients Fight Cancer Early
【Tungs' Hospital】Gastroscopy and Colonoscopy Reveal Hidden Tumors: Tungs' Hospital Helps Patients Fight Cancer Early

MoreTungs' HospitalInformation Mr. G, from the Philippines, came to Taiwan with his family and friends for a health checkup. It was his first time undergoing a gastroscopy and colonoscopy. Feeling generally healthy, he had never considered such examinations before. During the procedure, the doctor discovered a tumor about 2 centimeters in size in his colon. This was a shocking revelation for Mr. G, as he had experienced no discomfort or abnormal symptoms. Further biopsy results confirmed the tumor to be colorectal cancer! Did you knowmark class="has-inline-color has-ast-global-color-1-color" style="box-sizing: inherit; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">colorectal cancer/mark>is the third most common cancer worldwide? According to statistics from the World Health Organization (WHO), millions of people are diagnosed with this disease annually. Furthermore, data from WHO and the International Agency for Research on Cancer (IARC) show thatcolorectal cancer is the second leading cause of cancer-related deaths globally, second only to lung cancer. Since colorectal cancer often presents no noticeable symptoms in its early stages, many patients are only diagnosed at an advanced stage, significantly increasing the difficulty and risks associated with treatment. Fortunately, Mr. G’s colorectal cancer was detected at an early stage during his health checkup. The Tungs’ Hospital medical team promptly confirmed the diagnosis, communicated with Mr. G and his family, and provided the best treatment options. The team recommended robotic-assisted surgery using themark class="has-inline-color has-ast-global-color-0-color" style="box-sizing: inherit; background-image: initial; background-position: 0px 0px; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">da Vinci system/mark>to remove the tumor. Compared to traditional surgery, the da Vinci procedure offerssmaller incisions, less bleeding, reduced postoperative pain, and significantly shorter recovery times. After discussing with his family, Mr. G decided to opt for this advanced treatment, and the hospital quickly arranged the surgical plan. During the surgery, the medical team successfully removed a 20-centimeter diseased section from Mr. G’s colon. Thanks to the da Vinci minimally invasive procedure, his incisions were smaller, blood loss was minimal, and his recovery was exceptionally smooth. By the second day, Mr. G could already get out of bed and walk, resuming normal activities in a short time. The entire treatment journey was completed in less than two weeks: from the initial health checkup, diagnosis, and surgery to discharge—. Mr. G returned to his home country fully treated, with his experience earning high praise from both him and his family for Tungs’ Hospital’s efficiency and professionalism. Mr. G’s case serves as a powerful reminder of the importance of regular health checkups. Early detection of diseases significantly improves treatment success rates, prevents progression, and reduces the need for prolonged and costly treatments. Tungs’ Hospital remains committed to providing efficient, precise medical care with advanced technology and meticulous examination processes, offering timely support to patients from all over the world. In the future, we will continue to help more patients with early detection and effective treatment, striving to be your trusted guardian of health. If you have any further questions or want to know more medical information, feel free to visit our websites: IMedS Offical Website Facebook Instagram WhatsApp __________ Data Sources https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing–amidst-mounting-need-for-services https://www.who.int/news-room/fact-sheets/detail/cancer https://www.unitypoint.org/news-and-articles/most-dangerous-cancers-in-men-and-women https://seer.cancer.gov/statfacts/html/common.html https://www.statista.com/statistics/288580/number-of-cancer-deaths-worldwide-by-type

#Cancer Treatment#Robotic Surgery#Health Screening#Medical Tourism
【Tungs' Hospital】 Breakthrough in Joint Degeneration with Adipose-Derived Stem Cells: Elderly Regains Healthy Knees in Two Weeks
【Tungs' Hospital】 Breakthrough in Joint Degeneration with Adipose-Derived Stem Cells: Elderly Regains Healthy Knees in Two Weeks

Visit:【Tungs' Hospital】Taiwan Medical Travel Grandpa Huang, Bionet, and Tungs' Hospital Medical Team celebrate recovery Stem cell therapy for knee osteoarthritis is becoming a global trend in regenerative medicine! Tungs' Hospital, in collaboration with BIONET, treated 80-year-old Grandpa Huang for Osteoarthritis using Adipose-derived stem cell therapy. His knee pain, which had plagued him for five years, improved within just two weeks. Taiwan's healthcare system and health insurance are widely recognized for their excellence. According to the 2023 Global Healthcare Index released by the global database site Numbeo, Taiwan has ranked first worldwide for five consecutive years. Along with the recent regulatory relaxation of cell therapy under the "Regenerative Medicine Law," Tungs' Hospital has accumulated substantial real-world data on indications related to regenerative medicine and tissue repair. Dr. Ou Yanquan, director of the Innovation Center at Tungs' Hospital, expressed his enthusiasm for welcoming patients from around the world to Taiwan’s international-grade medical centers for Adipose-derived stem cell therapy, regardless of nationality. "When I heard that I would need a knee replacement and at least three months of post-surgery rehabilitation, I was terrified!" Grandpa Huang's knee joints naturally degenerated with age. Over five years, he underwent conservative treatments such as medication, hyaluronic acid, and PRP, but his knee pain persisted. Walking and climbing stairs at home were difficult. He then switched to Tungs' Hospital, where he received Adipose-derived stem cell therapy. Within two weeks, he experienced reduced pain and swelling in his knee joints and improved mobility in daily activities. Now, he can drive and climb stairs with ease and is overjoyed with the results. Grandpa Huang's knee x-ray before treatment (showed visible joint narrowing due to Osteoarthritis) !-- wp:paragraph {"style":{"elements":{"link":{"color":{"text":"var:preset|color|ast-global-color-5"}}}},"textColor":"ast-global-color-5"} --> !-- /wp:paragraph --> !-- wp:paragraph {"style":{"typography":{"lineHeight":1.6}},"fontSize":"medium"} --> !-- /wp:paragraph --> Dr. Zheng Yujie from the Orthopedics Department at Tungs' Hospital stated that, unlike traditional knee replacement surgery—which often worries patients due to the risk of infection and a lengthy rehabilitation period of three to six months—stem cell therapy offers an alternative for those with knee degeneration and sports injuries. Dr. Zheng shared the story of Mr. Bai, a Chinese-American in his 50s who loves sports but had knees similar to those of a 70-year-old. Despite receiving similar treatments in the U.S., his condition did not improve. Hearing about Grandpa Huang’s recovery, Mr. Bai was inspired to return to Taiwan for treatment, hoping that stem cell therapy could finally relieve his pain. Compared to medical costs in the U.S., Adipose-derived stem cell therapy for Osteoarthritis in Taiwan is far more affordable, saving patients up to six months of post-surgery rehabilitation time—making it a more economically viable solution. Dr. Zheng emphasized that in the past, the treatment for Osteoarthritis before reaching the stage of knee replacement typically involved painkillers, as well as advice to avoid squatting, kneeling, and climbing stairs. If pain persisted after six months of medication, treatments like hyaluronic acid injections or PRP would be considered to alleviate symptoms. However, the mechanism of action of Adipose-derived stem cells is different; these active stem cells can actively and effectively repair joint cartilage and suppress inflammation. Additionally, they can repair minor damage to the meniscus inside the knee joint, making this therapy beneficial not only for the elderly but also for those suffering from sports-related knee injuries. Dr. Cai Zhengxian, chairman of BIONET, stated that Adipose-derived stem cells have regenerative and repair capabilities, and they are also applicable for tendon and ligament injuries. Recently, in collaboration with the National Pingtung University of Science and Technology, they conducted preclinical animal studies, using Adipose-derived stem cells to treat cartilage defects in knee joints. MRI observations showed significant cartilage regeneration after the injection, confirming both safety and efficacy. The results have been published in an international journal and have received international recognition. Dr. Cai hopes that more patients in need will see these results and come to Taiwan for treatment. According to a report by Polaris Market Research, the global Osteoarthritis market is expected to reach USD 15.3 billion by 2030, with a compound annual growth rate of 8.5% from 2022 to 2030. Tungs' Hospital President Dr. Tong Minzhe presented Grandpa Huang with a sports equipment set as a gift. Dr. Ou Yanquan, Director of the Innovation Center at Tungs' Hospital, emphasized that stem cell therapy is an emerging medical technology. Previously, patients had to travel abroad for treatment, but with the initiation of local stem cell therapy programs, patients can now receive treatment in Taiwan, improving convenience. Dr. Tung Min-Che, the President of Tungs' Hospital, highlighted that the hospital continues to innovate in medical care, striving to upgrade advanced, precise, and regenerative medical technologies. Tungs' Hospital aims to provide higher-quality healthcare services, not only for the people of Taiwan but also for international patients in need, with the goal of becoming a trusted hospital for global citizens. Translated from: https://www.ctee.com.tw/news/20230823700832-431205

#Joint Replacement#Health Screening
Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences
Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences

Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences o:p>/o:p> Proton therapy is an advanced particle radiation treatment for cancer. The Proton Therapy Center at China Medical University Hospital (CMUH), which began operations this year, is the first institution in central Taiwan to offer proton radiation therapy. The center has already treated several patients with positive outcomes. Notably, two patients with rectal cancer showed significant tumor shrinkage and are now proceeding with further treatments, including surgery. CMUH, as part of its New Southbound Policy initiative, is promoting the results and experiences of proton therapy in Malaysia, where it has sparked significant attention and lively discussions.o:p>/o:p> Third Year of the New Southbound Policy: CMUH Hosts Smart Health Transformation Forum in Malaysiao:p>/o:p> This is the third year CMUH has executed the Ministry of Health and Welfare's (MOHW) "New Southbound Medical Cooperation and Industry Development Plan." Led by Dr. Chih-Kun Huang, Superintendent of the Body Science & Metabolic Disorders International Medical Center at CMUH, a six-member team specializing in proton radiation, metabolic surgery, and reconstructive surgery traveled to Kuala Lumpur on the 17th. They hosted the “2024 Smart Health Transformation Forum – Proton Therapy & Metabolic Surgery & Plastic Surgery” in collaboration with International Medical University (IMU) of Malaysia, with which CMUH had signed a memorandum of understanding (MOU). The forum facilitated in-depth exchanges on advanced technologies and achievements, including proton therapy, with Malaysia’s academic and medical communities. Ms. Ling-Ying Wu, Principal Assistant Director of the Taipei Economic and Cultural Office in Malaysia, praised CMUH’s dedication to deepening partnerships with MOU institutions and recognized the hospital's significant efforts in fostering Taiwan-Malaysia medical exchanges. MOHW, therefore, entrusted CMUH with this critical task and promised continued support to move forward together.o:p>/o:p> Promoting Cutting-Edge Medical Innovations to Malaysia through New Southbound Exchangeso:p>/o:p> On the 17th, CMUH partnered with Malaysia’s IMU to co-host the “2024 Smart Health Transformation Forum – Proton Therapy & Metabolic Surgery & Plastic Surgery” in Kuala Lumpur. Participants included prominent medical figures: Ms. Ling-Ying Wu (3rd from the right), Dr. Chih-Kun Huang (5th from the right), Dr. Jian-Jr Lee, Vice Superintendent of the CMU Central Taiwan Healthcare System and Director of the Department of Plastic and Reconstructive Microsurgery Surgery, CMUH (2nd from the right), Dr. Chun-Ru Chien, Director of the Division of Particle Therapy, CMUH (6th from the right), Dr. Shyun-Jing Wee, Attending Physician of the Department of Plastic and Reconstructive Microsurgery Surgery, CMUH (1st from the right), CEO Ai-Chi Chou, Executive Director of the International Medical Center, CMUH (7th from the right), and Professor Wong Shew Fung, Associate Director of Research and Innovation at IMU (4th from the right).o:p>/o:p> Taiwan’s Latest Proton Therapy Center: Minimizing Damage to Healthy Tissue, Shrinking Rectal Cancer Tumors without Major Side Effectso:p>/o:p> The Proton Therapy Center at CMUH is the newest of Taiwan’s four centers, equipped with 360-degree precise positioning and integrated with surgery, immunotherapy, cellular therapy, and one-stop international medical services to provide high-quality treatments. Dr. Chun-Ru Chien, Director of the Division of Particle Therapy at CMUH, noted that mid-stage rectal cancer often requires preoperative pelvic radiation therapy to shrink the tumor for subsequent surgery. However, pelvic radiation can lead to mild but common digestive and urinary side effects. Proton therapy, by contrast, is expected to significantly reduce the incidence of these side effects. Unlike photon radiation therapy, proton therapy minimizes unnecessary radiation to surrounding healthy tissue, thus reducing side effects. It is suitable for treating tumors throughout the body, especially those located in sensitive areas or near vital organs, such as brain tumors, head and neck cancers, breast cancer, lung cancer, esophageal cancer, liver cancer, prostate cancer, and recurrent tumors. It also holds promise for pediatric cancer patients, where it can reduce long-term complications, offering hope to more patients in need.o:p>/o:p> Robotic Minimally Invasive Surgery for Obesity: Precision Medicine Delivers Personalized Treatment Planso:p>/o:p> At the forum, Dr. Chih-Kun Huang, an expert in bariatric and metabolic surgery, shared the latest advancements and treatment philosophies. He emphasized that, in Malaysia, with the rising obesity rate, traditional treatments like lifestyle changes and medications are limited, creating an urgent need for innovative solutions. Recent advances in pharmacotherapy have introduced new anti-obesity drugs targeting appetite and energy balance. Additionally, bariatric surgery has seen the introduction of robotic minimally invasive surgery, and new insights into hormonal regulation of the gastrointestinal system have emerged. Precision medicine, including genetic and microbiome research, is also offering personalized treatment plans.o:p>/o:p> Stem Cells and Exosome Tissue Regeneration: A Breakthrough in Wound Healing Surpassing Traditional Methodso:p>/o:p> Dr. Jian-Jr Lee, Vice Superintendent of CMUH’s Fengyuan Branch and expert in plastic and reconstructive surgery, discussed the use of stem cells and exosomes in wound treatment. Stem cells possess the ability to differentiate into various cell types, making them crucial for tissue repair and regeneration. In wound healing, stem cells can transform into skin cells, blood vessels, and other essential components, accelerating recovery, reducing scarring, and improving outcomes for patients with chronic or complex wounds. Exosomes derived from stem cells stimulate cell proliferation, angiogenesis, and immune modulation, making exosome therapy a powerful tool in enhancing the body's natural healing mechanisms. CMUH fully leverages the regenerative potential of stem cells and the signaling properties of exosomes, achieving wound healing results that surpass traditional treatments.o:p>/o:p> Combining Super Microsurgery with 3D Printing: Precision Treatment for Head and Neck Cancer, Balancing Functionality and Aestheticso:p>/o:p> Dr. Shyun-Jing Wee, a plastic and reconstructive surgeon at CMUH, explained that CMUH’s reconstructive team has integrated super microsurgery with CAD/CAM and 3D printing technologies for head and neck cancer surgeries. These advancements allow for more precise tumor localization and treatment, offering personalized surgical options that optimize both functional and aesthetic outcomes, improving patients' quality of life.o:p>/o:p> Deepening Cooperation with New Southbound MOU Institutions: Expanding Successful Experiences and Enhancing Taiwan's Medical Brand Reputationo:p>/o:p> CEO Ai-Chi Chou, Executive Director of CMUH’s International Medical Center, stated that after signing an MOU with IMU in May, the hospital participated in the “2024 Next Generation of Care Conference” hosted by IMU, showcasing CMUH’s smart hospital technology in partnership with Wiicare and Wearable Wisdom (Keeogo). Datuk Dr. Muhammad Radzi bin Abu Hassan, Director-General of the Malaysian Ministry of Health, was highly impressed by the exhibition. This is the second collaboration between the two parties, focusing on CMUH’s cutting-edge medical innovations, including proton therapy, metabolic surgery, stem cells, exosomes, and super microsurgery. Through ongoing partnerships with MOU institutions, CMUH aims to build a foundation of trust and friendship, replicating its successful model across East Malaysia’s medical institutions and boosting the global reputation and favorability of Taiwan's medical brand. International Center / China Medical University Hospital(Taiwan) https://www.cmuh.cmu.edu.tw/Department/Detail_EN?depid=111 Tel:+886-4-22052121#12961~129641 E-mail:imc@tool.caaumed.org.tw o:p>/o:p>

First page

1 2 3 4

Last Page

Is the information helpful to you? Yes No

Central Taiwan

【Tungs Hospital】Halcyon™: Treat & Monitor | Cancer Radiotherapy

[Taiwan–Malaysia Medical Innovation Forum] CMUH and UNIMAS Co-Host Major Medical Symposium to Advance Medical Technology and Precision Patient Care

【Tungs' Hospital】 Former Stage III Prostate Cancer Patient Shares Da Vinci Surgery Experience

【Tungs' Hospital】U.S. Teacher Regained Hope After Devastating Car Accident

【Tungs’ Hospital】 Earns 4-Star in Global Hospital Rankings

Heart Surgery for Mitral Valve Regurgitation

【Tungs' Hospital】Gastroscopy and Colonoscopy Reveal Hidden Tumors: Tungs' Hospital Helps Patients Fight Cancer Early

【Tungs' Hospital】 Breakthrough in Joint Degeneration with Adipose-Derived Stem Cells: Elderly Regains Healthy Knees in Two Weeks

Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences